This webinar describes the use of NanoString’s nCounter® Analysis System for immuno-oncology related gene expression profiling of FFPE tissue samples. The results of two recent publications using the nCounter platform are reviewed, including one study that investigated the transcriptional profile of FFPE clear cell renal cell cancer (RCC) tissues using both NanoString’s Pan Cancer Immune Profiling panel and an RNA-Seq based immune response assay.
Canopy Biosciences is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
I agree to receive marketing communications from Canopy Biosciences.
You can unsubscribe from these communications at any time by clicking the Unsubscribe link at the bottom of any of the emails we've sent you. View our Privacy Policy for more information.
By clicking submit below, you consent to allow Canopy Biosciences to store and process the personal information submitted above to provide you the content requested.